PTC Therapeutics Inc. buy UBS Group AG
Start price
26.08.24
/
50%
€31.00
Target price
26.08.25
€42.11
Performance (%)
1.29%
Price
27.08.24
€31.20
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 1.29%. This prediction currently runs until 26.08.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
PTC Therapeutics Inc. | 1.29% |
iShares Core DAX® | 1.743% |
iShares Nasdaq 100 | -2.088% |
iShares Nikkei 225® | 1.306% |
iShares S&P 500 | -0.093% |
Comments by UBS_Group_AG for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $47.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat